The results confirm that the efficacy of the TAK-242 intervention can reduce arsenic-induced thyroid inflammatory injury and dysfunction by inhibiting the TLR4/NF-κB signaling pathway, thereby reducing the arsenic-induced inflammatory damage and dysfunction of the thyroid gland. The gene discussed is TLR4; the disease is thyroid gland disorder.